Landscapes / Targets
5-HT2C
5 drugs act on 5-HT2C, in 9 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs5
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Atypical antipsychotic |
AbbVie · Public ABBV |
Approved | 15 Dec 2026soonPhase 3 trial completes | ||
| Next date | 15 Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | Schizophrenia, Depression and 1 more | ||||
| Open drug page | |||||
Fenfluramine HClnot checked |
— |
Approved | 6 Feb 2029Phase 3 trial completes | ||
| Next date | 6 Feb 2029 · Phase 3 trial completes | ||||
| Also tested for | Rett Syndrome | ||||
| Open drug page | |||||
— |
Phase 3 | 31 Dec 2026Phase 3 trial completes | |||
| Next date | 31 Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | Developmental and Epileptic Encephalopathy, Dravet Syndrome | ||||
| Open drug page | |||||
— |
Phase 3 | — | |||
| Also tested for | Schizophrenia | ||||
| Open drug page | |||||
5-HT2C agonist unconfirmed |
Bright Minds Biosciences · Public DRUG |
Phase 2 | Nov 2026soonPhase 2 trial completes | ||
| Next date | Nov 2026 · Phase 2 trial completes | ||||
| Also tested for | Absence Epilepsy, Jeavons Syndrome and 3 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 4 of 5 drugs. The other 1 is marked “not checked” in the list. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026